MS Academy Educational Webinars

Hot topics that matter today: Clinical vulnerability and vaccination


 

The MS Academy is a medical education initiative by Bayer AG. The 2021 program focusses on the current hot topics of clinical vulnerability and vaccination in MS and is chaired by Professor Mar Tintore, CEMCAT, University Hospital Vall d'Hebron, Barcelona, Spain.

 

Program

The option to register depends on the country you live in as legal regulations are country specific. In case of questions, please contact your local Bayer representative.

 

    Multiple sclerosis in the ageing population


     

    September 7, 18 – 19h CET

     

    Over half of the patients with MS in western countries are now 45 years of age or older; a general trend towards increased longevity in patients with MS is noticed (1-4). Beyond the visible signs of ageing, becoming older also means a higher likelihood of immunosenescence, inflamm-ageing, co-morbidities, and less biological reserve. Not everyone ages equally quickly and chronological and biological age may differ. Patients with MS seem to be susceptible to accelerated biological ageing and may therefore be ‘older’ than their years (5). At the same time age affects MS (1). These issues as well as the interplay with co-morbidities have so far received relatively little attention. The objective of this webinar is to shed light on those topics and to discuss how to better consider the special needs of older patients with MS or of those with co-morbidities, in order to ultimately improve the management of the ageing population with MS.

     

    Speaker’s bureau

     

    Mar Tintore, CEMCAT, University Hospital Vall d'Hebron, Barcelona, Spain, Chairperson

    Jennifer Graves, University of California San Diego Health, San Diego, CA, USA

    Sven Meuth, University Hospital Düsseldorf, Düsseldorf, Germany

     

    Agenda

     

    18.00 – 18.05

    Welcome and introduction

    Mar Tintore

    18.05 – 18.30

    MS in the ageing population: (Neuro)immunological aspects

    Sven Meuth

    18.30 – 18.55

    MS in the ageing population: Current data and lessons for clinical practice

    Jennifer Graves

    18.55 – 19.00

    Closing remarks

    Mar Tintore

     

    Registration is open! Please ask your local delegate.

     

    Whether you are entitled to register depends on the country where you live as legal regulations are country specific. In case of questions, please contact your local Bayer representative.  

    References

    Infections in patients with MS: Neurology and infectiology viewpoints 


     

    October 27, 18 – 19h CET

     

    MS patients have an increased risk of infections compared to the general population (1,2). Several factors influence the risk of infections in patients with MS such as the patient’s disability severity, the patient’s age, the treatment he/she is taking or the patient’s overall health (3-5). This session is a deep dive into MS and infections and on what makes MS patients more vulnerable to infections: Pathomechanisms, frequency, available data, influence of therapy and lessons learned for clinical management will be reviewed from the neurology and infectiology viewpoint.

     

    Speaker’s bureau

     

    Mar Tintore, CEMCAT, University Hospital Vall d'Hebron, Barcelona, Spain, Chairperson

    Anthony Reder, University of Chicago, Chicago, USA

    Isabel Ruiz, CEMCAT, University Hospital Vall d'Hebron, Barcelona, Spain

     

    Agenda

     

    18.00 – 18.05

    Welcome and introduction

    Mar Tintore

    18.05 – 18.30

    Infections in patients with MS

    • Neurology viewpoint: Frequency and clinical data
    • Infectiology viewpoint: Frequent infections and pathomechanisms

     

    Anthony Reder

    Isabel Ruiz

     

    18.30 – 18.55

    Clinical management

    • Infectiological considerations
    • Neurological considerations

     

    Isabel Ruiz

    Anthony Reder

     

    18.55 – 19.00

    Closing remarks

    Mar Tintore

     

    Save the dates, registration will open soon!

    Whether you are entitled to register depends on the country where you live in as legal regulations are country specific. In case of questions, please contact your local Bayer representative.

    References

    Multiple sclerosis and immunization: Insights into the new ECTRIMS/EAN immunization recommendations


     

    November 16, 18 – 19h CET

     

    The subject of vaccination is scientifically complex, and the complexity increases when the patient suffers from a chronic disease like MS and takes a medication which interacts with immune mechanisms (1,2). As a clinician you are challenged to have well-founded answers to your patients' questions. At least in some countries, national guidelines have been developed which provide important guidance on the subject (3-5). Currently the joint ECTRIMS/EAN initiative is making efforts to establish international vaccination recommendations. The guidelines are anticipated to be presented at ECTRIMS 2021. This webinar will provide you with insights into these new recommendations and – out of actuality – discuss aspects related to COVID 19 vaccination and MS. The interactive panel discussion will allow to discuss your clinical questions. around MS and vaccination with experts from the initiative.

     

    Speaker’s bureau

     

    Mar Tintore, CEMCAT, University Hospital Vall d'Hebron, Barcelona, Spain, Chairperson

    Susana Otero, Department of Preventive Medicine and Epidemiology, University Hospital Vall d'Hebron, Barcelona, Spain

    Massimo Filippi, Neurology Unit, MS Center, IRCCS San Raffaele Scientific Institute, Milan, Italy.

     

    Agenda

     

    18.00 – 18.05

    Welcome and introduction

    Mar Tintore

    18.05 – 18.20

    Insights into the new recommendations

    Susana Otero

    18.20 – 18.30

    COVID vaccination in MS: Experience and aspects to consider

    Massimo Filippi

    18.30 – 18.55

    Interactive panel discussion

     

    18.55 – 19.00

    Closing remarks

    Mar Tintore

     

    Save the dates, registration will open soon!

    Whether you are entitled to register depends on the country where you live in as legal regulations are country specific. In case of questions, please contact your local Bayer representative.

    References

    References

    Alt tag